Enochian Biosciences | Results Presentation Deck | 43 slides

Renovaro Biosciences · 2023-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

43
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
establish_context
04
inspire_vision
05
The slide uses a visual metaphor of donor vs patient cells to explain the mechanism of action.present_solution
06
The slide uses a chevron-based process flow to map disease states to market validation.size_opportunity
07
The slide uses a flow-based diagram to show how pipeline assets are developed and then monetized through various business strategies.present_solution
08
The slide uses a Gantt-style timeline to show progress of various therapeutic programs.plan_implementation
09
The slide uses a card-based layout to display five key executives with their titles and previous company affiliations.other
11
cite_precedent
12
transition
13
The slide uses a quote from a subject matter expert to build credibility.cite_precedent
14
The slide uses a biological process diagram to illustrate the mechanism of immune activation.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
15
The slide uses a visual comparison to illustrate two distinct evasion strategies: starving killer T-cells and recruiting protective T-reg cells.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
16
The diagram uses a callout-style list to map specific cellular functions to a central dendritic cell illustration.present_solution
Open slide detailBeat · Solution
17
The slide uses a circular process flow to represent the manufacturing cycle of a personalized cell therapy.present_solution
Open slide detailBeat · Solution
18
Includes statistical significance markers (p-values) and sample sizes (n).show_traction
Open slide detailLoop · Quick Win Big Bet
19
The slide acts as a pointer to a specific external scientific presentation.appendix
Open slide detailLoop · Quick Win Big Bet
20
The slide uses a ribbon-style process diagram to show progression.plan_implementation
Open slide detailBeat · Impact & Next Steps
21
present_solution
Open slide detailBeat · Impact & Next Steps
22
transition
Open slide detailBeat · Impact & Next Steps
23
present_solution
Open slide detailBeat · Impact & Next Steps
24
The slide features the Renovaro Biosciences logo and a stylized botanical/cellular graphic background.transition
Open slide detailBeat · Impact & Next Steps
25
The slide uses a process flow diagram to explain the therapeutic intervention.present_solution
Open slide detailBeat · Impact & Next Steps
26
The slide uses a chevron-style process flow to represent chronological progress.plan_implementation
Open slide detailBeat · Impact & Next Steps
27
transition
Open slide detailBeat · Impact & Next Steps
28
present_solution
Open slide detailBeat · Impact & Next Steps
29
The chart shows a significant drop in viral load starting around day 14, stabilizing at a low level from day 145 onwards.show_traction
Open slide detailBeat · Impact & Next Steps
30
plan_implementation
Open slide detailBeat · Impact & Next Steps
31
front_matter
Open slide detailBeat · Impact & Next Steps
32
present_solution
Open slide detailBeat · Impact & Next Steps
33
transition
Open slide detailBeat · Impact & Next Steps
34
present_solution
Open slide detailBeat · Impact & Next Steps
35
The slide uses a comparative diagram to illustrate the selective mechanism of action.present_solution
Open slide detailBeat · Impact & Next Steps
36
The slide uses a ribbon-style process diagram to represent sequential or cumulative progress.plan_implementation
Open slide detailBeat · Impact & Next Steps
37
The slide uses a quote from a key advisor to validate the scientific potential of the company's technology beyond its primary cancer focus.cite_precedent
Open slide detailBeat · Impact & Next Steps
38
transition
Open slide detailBeat · Impact & Next Steps
39
other
Open slide detailBeat · Impact & Next Steps
40
transition
Open slide detailBeat · Impact & Next Steps
41
The slide uses a horizontal arrow-based timeline structure to map specific drug candidates to their upcoming regulatory and clinical milestones.plan_implementation
Open slide detailBeat · Impact & Next Steps
42
state_next_steps